Becton Dickinson

Becton Dickinson

Develops and sells medical devices and diagnostics

About Becton Dickinson

Simplify's Rating
Why Becton Dickinson is rated
B
Rated A on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Biotechnology

Healthcare

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Overview

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company operates in three main areas: BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. BD develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to hospitals, laboratories, and healthcare providers worldwide. Their products aim to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in medical care. What sets BD apart from competitors is its comprehensive approach to healthcare solutions across various segments, allowing for a wide range of services and products. The company's goal is to advance healthcare by providing effective tools and technologies that improve the quality and accessibility of medical care.

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's $1.2B investment boosts syringe manufacturing and drug delivery capabilities.
  • AI integration in healthcare offers BD opportunities to enhance diagnostic accuracy and efficiency.
  • Growing demand for pre-fillable syringes aligns with BD's recent manufacturing investments.

What critics are saying

  • Increased competition in the syringe market may impact BD's market share.
  • Integration of Cubex LLC's assets may challenge BD's operational efficiency.
  • New executive appointments may lead to strategic shifts disrupting current operations.

What makes Becton Dickinson unique

  • BD's global reach spans North America, EMEA, Greater Asia, and Latin America.
  • BD's diverse segments include Medical, Life Sciences, and Interventional, covering various healthcare needs.
  • BD's focus on innovation enhances patient outcomes and operational efficiencies in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$460k

Above

Industry Average

Funded Over

2 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...

Recently Posted Jobs

Sign up to get curated job recommendations

Senior Director - Software Engineering

$199.6k - $359.3k/yr

San Diego, CA, USA

GIE EPI Engineer

Norfolk, NE, USA + 1 more

Peripheral Intervention Oncology - Territory Manager

Foley, AL, USA + 1 more

See All Jobs

Becton Dickinson is Hiring for 329 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Becton Dickinson's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Becton Dickinson

Baxter International

Baxter International

Deerfield, Illinois

Bristol Myers Squibb

Bristol Myers Squibb

New York City, New York

Abbott

Abbott

Lake Bluff, Illinois

GIE EPI Engineer

Norfolk, NE, USA + 1 more

Peripheral Intervention Oncology - Territory Manager

Foley, AL, USA + 1 more

See All Jobs

Becton Dickinson is Hiring for 329 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Becton Dickinson's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Becton Dickinson

Baxter International

Baxter International

Deerfield, Illinois

Bristol Myers Squibb

Bristol Myers Squibb

New York City, New York

Abbott

Abbott

Lake Bluff, Illinois